Skip to main content
Premium Trial:

Request an Annual Quote

Life Tech Certifies Asuragen, AltheaDx as Service Providers for Sequencing on PGM

Premium

Life Technologies has named both Asuragen and AltheaDx as authorized customer service providers for sequencing on its Ion Torrent PGM platform.

Asuragen offers targeted sequencing panels on the PGM, including its AsuraSeq custom cancer panels and the Ion AmpliSeq cancer panel, and can analyze samples from formalin-fixed paraffin-embedded tissue as well as samples collected from fine needle aspiration (CSN 1/4/2012).

AltheaDx, meantime, is using the PGM in its clinical molecular pathology laboratory for biomarker discovery and clinical trial testing, and offers sequencing services to pharmaceutical and biotechnology companies (CSN 7/6/2011).

Joe Monforte, AltheaDx's chief scientific officer, said in a statement that the company has already begun using the PGM in clinical studies and that it plans to "push ahead several of our companion diagnostic programs based on NGS."

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more